Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|3|372-383

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.3, 2015-08, pp. : 372-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 131, Iss. 4, 2013-12 ,pp. : 231-238

Karger

Access to resources Recommend Favorite

Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1036-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 590-593

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-04 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1

By  

Acta Haematologica, Vol. 129, Iss. 4, 2013-01 ,pp. : 243-250

Karger

Access to resources Recommend Favorite